Related Experiment Video

Updated: Jun 17, 2026

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis
07:27

Simplified Whole Body Plethysmography to Characterize Lung Function During Respiratory Melioidosis

Published on: February 24, 2023

[Melioidosis: an emerging tropical disease]

E Valade1, F M Thibault, F V Biot

  • 1Unité de Bacteriologie/UMR-MD1, Institut de Recherche Biomédicale des Armées/CRSSA, La Tronche. evalade@crssa.net

Medecine Tropicale : Revue Du Corps De Sante Colonial
|December 23, 2009
PubMed

Insights

Melioidosis is a serious infection caused by Burkholderia pseudomallei, a soil bacterium. Difficult to treat and lacking a vaccine, it poses a significant public health risk.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • One Health

Context:

  • Melioidosis is a significant zoonotic disease caused by Burkholderia pseudomallei, a Gram-negative bacterium found in soil.
  • It is endemic in tropical regions of Southeast Asia and Northern Australia, with sporadic cases globally.
  • The infection presents with diverse clinical manifestations, from acute septicemia to chronic conditions.

Purpose:

  • To provide a comprehensive overview of melioidosis, its causative agent, and its impact on human and animal health.
  • To highlight the challenges in diagnosis and treatment due to antibiotic resistance and lack of a vaccine.
  • To underscore the public health significance and potential bioterrorism concerns associated with Burkholderia pseudomallei.

Summary:

  • Burkholderia pseudomallei causes melioidosis, a variable infection affecting humans and animals.
  • Treatment is challenging due to widespread antibiotic resistance and the absence of a vaccine, leading to common relapses.
  • The bacterium's high virulence and resistance profile classify it as a biological risk agent.

Impact:

  • Increased awareness of melioidosis as a critical infectious disease in endemic and non-endemic areas.
  • Highlights the urgent need for novel therapeutic strategies and vaccine development against Burkholderia pseudomallei.
  • Emphasizes the importance of One Health approaches for managing zoonotic diseases with bioterrorism potential.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Superior Auto-Identification of Trypanosome Parasites by Using a Hybrid Deep-Learning Model08:20

Superior Auto-Identification of Trypanosome Parasites by Using a Hybrid Deep-Learning Model

Published on: October 27, 2023

Related Concept Videos

Toxoplasmosis01:28

Toxoplasmosis

Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...